| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 02/17/2004 | US6692943 Persephin and related growth factors |
| 02/17/2004 | CA2280279C Indole, indazole and benzimidazole derivatives as antithrombotic agents |
| 02/17/2004 | CA2124680C Piperazine derivatives as 5-ht1a antagonists |
| 02/17/2004 | CA2051501C 1-phenyl-3-phenyl-2-propyne-1-ones as calcium uptake inhibitors |
| 02/12/2004 | WO2004013309A2 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 02/12/2004 | WO2004013285A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | WO2004013173A1 Novel potassium-dependent sodium-calcium exchanger |
| 02/12/2004 | WO2004013146A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 02/12/2004 | WO2004013144A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/12/2004 | WO2004013142A1 A riboflavin derivative and its manufacture and uses |
| 02/12/2004 | WO2004013141A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 02/12/2004 | WO2004013140A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 02/12/2004 | WO2004013138A2 Imidazo`1,2-a!pyridines |
| 02/12/2004 | WO2004013135A1 2-phenylpyridin-4-yl derivatives as alk5 inhibitors |
| 02/12/2004 | WO2004013134A2 Compounds |
| 02/12/2004 | WO2004013132A1 Furanthiazole derivatives as heparanase inhibitors |
| 02/12/2004 | WO2004013130A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 02/12/2004 | WO2004013125A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 02/12/2004 | WO2004013119A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 02/12/2004 | WO2004013114A1 Aminoalkyl-substituted aryl compounds and their use as sodium channel blockers |
| 02/12/2004 | WO2004013109A1 Resorcinol derivative |
| 02/12/2004 | WO2004013108A1 Method and compounds for promoting healing and reducing inflammation |
| 02/12/2004 | WO2004013102A1 Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines |
| 02/12/2004 | WO2004013085A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | WO2004013083A1 Nolomirole hydrochloride form i |
| 02/12/2004 | WO2004012775A2 Bicistronic vector encoding a vegf and an fgf, use thereof |
| 02/12/2004 | WO2004012761A1 Methods of use of compounds with preptin function |
| 02/12/2004 | WO2004012759A2 Use of erythropoietin |
| 02/12/2004 | WO2004012754A1 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 02/12/2004 | WO2004012732A2 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 02/12/2004 | WO2004012718A1 New film coating |
| 02/12/2004 | WO2004012686A2 Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use |
| 02/12/2004 | WO2004012671A2 Substituted furo [2,3-b] pyridine derivatives |
| 02/12/2004 | WO2004012653A2 Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 02/12/2004 | WO2004012651A2 Composition for heart disease, method to prepare same and uses thereof |
| 02/12/2004 | WO2003103604A3 Gamma lactams as prostaglandin agonists and use thereof |
| 02/12/2004 | WO2003091259A8 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors |
| 02/12/2004 | WO2003070236A3 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2003051346A3 Use of selective pde5 inhibitors for treating partial and global respiratory failure |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2003044524A3 Methods and means for influencing intracellular communication and intracellular organelle transport |
| 02/12/2004 | WO2003037916A3 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/12/2004 | WO2003033653B1 Affinity enhancement agents |
| 02/12/2004 | WO2003029209A3 Chemical compounds |
| 02/12/2004 | WO2003020700A3 SUBSTITUTED INDENO[1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 02/12/2004 | WO2003010159A8 Piperidine derivatives as nmda receptor antagonists |
| 02/12/2004 | WO2003008365A3 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 02/12/2004 | WO2002100330A3 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 02/12/2004 | WO2002074346A3 Targeting chemical compounds to cells |
| 02/12/2004 | WO2002068461A3 Heterocarpine, a human ghrh-binding protein |
| 02/12/2004 | WO2002066647A3 Type 2 ctokine receptor and nucleic acids encoding same |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | WO2002057454A3 Receptors and membrane-associated proteins |
| 02/12/2004 | WO2002053700A3 Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| 02/12/2004 | WO2002053580A3 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 02/12/2004 | US20040030380 Drug-delivery endovascular stent and method for treating restenosis |
| 02/12/2004 | US20040030141 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them |
| 02/12/2004 | US20040030138 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 02/12/2004 | US20040030096 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 02/12/2004 | US20040029959 Isosorbide mononitrate compositions and methods of their use |
| 02/12/2004 | US20040029954 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029945 Method of inhibiting matrix metalloproteinases |
| 02/12/2004 | US20040029943 Antiallergens; antiinflammatory agents; hypotensive agents; central nervous system disorders |
| 02/12/2004 | US20040029940 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029938 Medicaments |
| 02/12/2004 | US20040029937 Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 02/12/2004 | US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/12/2004 | US20040029933 Substituted phenylacetic acids |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029929 Aminoadamantane derivatives as therapeutic agents |
| 02/12/2004 | US20040029925 Central nervous system disorders; psychological disorders; gastrointestinal disorders |
| 02/12/2004 | US20040029917 Benzosuberonylpiperdine compounds as analgesics |
| 02/12/2004 | US20040029901 Obesity therapy; administering orlistat |
| 02/12/2004 | US20040029900 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidines with a phosphodiesterase v-inhibiting effect |
| 02/12/2004 | US20040029899 Novel compounds |
| 02/12/2004 | US20040029890 PH sensitivity; controlling blood concentration; cardiovascular disorders |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029884 Cyclization in presence of Lawesson's reagent |
| 02/12/2004 | US20040029883 Beta-amino acid compounds as integrin antagonists |
| 02/12/2004 | US20040029880 Anthranyl amides and their use as medicaments |
| 02/12/2004 | US20040029876 Acylamino cyclopropane derivatives |
| 02/12/2004 | US20040029875 Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same |
| 02/12/2004 | US20040029874 Anticoagulants; cardiovascular disorders |
| 02/12/2004 | US20040029873 Antiinflammatory agents; Alzheimer's disease; atherosclerosis; inflammatory bowel diseases; antiarthritic agents |
| 02/12/2004 | US20040029870 Antiinflammatory agents |
| 02/12/2004 | US20040029868 Multiple sclerosis; atherosclerosis; inflamamtory bowel diseases; asthma |
| 02/12/2004 | US20040029866 Polymerase enzyme inhibitors |
| 02/12/2004 | US20040029864 Synergistic mixture of cyclooxygenase inhibitor and active drug |
| 02/12/2004 | US20040029863 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 02/12/2004 | US20040029854 Nirtic oxide donors based on metallic centres |
| 02/12/2004 | US20040029851 Therapy for oxidation stresses; complex of drug and enzyme mimetics |
| 02/12/2004 | US20040029850 Central nervous system disorders; antidepressants; bipolar disorders; rhematic diseases |
| 02/12/2004 | US20040029847 Anticancer agents; contraceptives |
| 02/12/2004 | US20040029845 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications |
| 02/12/2004 | US20040029827 Remedies for heart failure |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | US20040029811 N-alkylglycine trimeres capable of protecting neurons against excitotoxic aggressions and compositions containing such trimeres |
| 02/12/2004 | US20040029807 For therapy of hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock |